ArticleFrontiers in immunology2022

IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis.

Shuai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.